Examining the Results of Cervical Pap Smears at a Hospital Specializing in Advanced Medical Treatment
Authors/Creators
- 1. Assistant Professor, Department of Pathology, Lord Buddha Koshi Medical College and Hospital, Saharsa, Bihar, India
Description
Aim: The objective of the present investigation is the study of cervical pap smears in a tertiary care hospital. Methods and Material: This research was carried out at the Department of Pathology, Lord Buddha Koshi Medical College and Hospital, Saharsa, Bihar, and 50 women participants with cervical cancer disease were included. The duration of the study was one year. Local ideas and culture were incorporated. Confidentiality was assured. They were given thorough explanations in their native tongue about the purpose and aim of the survey. Result: There were 50 women subjects analyzed out of which the age range of 30-39 years had the highest percentage of cases (38%). The oldest case involved a 79-year-old man. A minimum of 4% of instances involved people under the age of 70-79. Conclusion: This test is an effective analytical tool for discerning cervical cancer. The results obtained from this study demonstrate that the pap test is exceedingly sensitive, specific, and accurate in detecting pre-cancerous changes in the cervix. Therefore, it is recommended that all women above the age of 20 should be routinely screened for cervical cancer with a pap test.
Abstract (English)
Aim: The objective of the present investigation is the study of cervical pap smears in a tertiary care hospital. Methods and Material: This research was carried out at the Department of Pathology, Lord Buddha Koshi Medical College and Hospital, Saharsa, Bihar, and 50 women participants with cervical cancer disease were included. The duration of the study was one year. Local ideas and culture were incorporated. Confidentiality was assured. They were given thorough explanations in their native tongue about the purpose and aim of the survey. Result: There were 50 women subjects analyzed out of which the age range of 30-39 years had the highest percentage of cases (38%). The oldest case involved a 79-year-old man. A minimum of 4% of instances involved people under the age of 70-79. Conclusion: This test is an effective analytical tool for discerning cervical cancer. The results obtained from this study demonstrate that the pap test is exceedingly sensitive, specific, and accurate in detecting pre-cancerous changes in the cervix. Therefore, it is recommended that all women above the age of 20 should be routinely screened for cervical cancer with a pap test.
Files
IJTPR,Vol13,Issue1,Article36.pdf
Files
(308.5 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:3f035b47e52cbbee591e81ac3b7ac44a
|
308.5 kB | Preview Download |
Additional details
Dates
- Accepted
-
2022-12-08
Software
References
- 1. Cohen PA, Jhingran A, Oaknin A, Denny L. Cervical cancer. The Lancet. 2019 Jan 12;393(10167):169-82. 2. Furumoto H, Irahara M. Human papilloma virus (HPV) and cervical cancer. Journal of Medical Investigation. 2002 Aug 1;49(3/4):124- 33. 3. Creasman WT. Preinvasive disease of the cervix. Clinical Gynecologic Oncology. Philadelphia. 2007 Jan 1:1- 5. 4. Basu P, Banerjee D, Singh P, Bhattacharya C, Biswas J. Efficacy and safety of human papillomavirus vaccine for primary prevention of cervical cancer: A review of evidence from phase III trials and national programs. South Asian journal of cancer. 2013 Oct;2(04):187-92. 5. Rodriguez-Carunchio L, Soveral I, Steenbergen RD, Torné A, Martinez S, Fusté P, Pahisa J, Marimon L, Ordi J, Del Pino M. HPV-negative carcinoma of the uterine cervix: a distinct type of cervical cancer with poor prognosis. BJOG: An International Journal of Obstetrics & Gynaecology. 2015 Jan;1 22(1):119-27. 6. Ribeiro AA, Costa MC, Alves RR, Villa LL, Saddi VA, Carneiro MA, Zeferino LC, Rabelo-Santos SH. HPV infection and cervical neoplasia: associated risk factors. Infectious agents and cancer. 2015 Dec; 10:1-7. 7. Ruiz ÁM, Ruiz JE, Gavilanes AV, Eriksson T, Lehtinen M, Pérez G, Sings HL, James MK, Haupt RM, FUTURE I and II Study Group. Proximity of first sexual intercourse to menarche and risk of high-grade cervical disease. The Journal of infectious diseases. 2012 Dec 15;206 (12):1887-96. 8. Hawkins NA, Cooper CP, Saraiya M, Gelb CA, Polonec L. Why the Pap test? Awareness and use of the Pap test among women in the United States. Journal of Women's Health. 2011 Apr 1;20(4):511-5. 9. Koss LG. The Papanicolaou test for cervical cancer detection: a triumph and a tragedy. Jama. 1989 Feb 3;261 (5):737-43. 10. Walter LC, Covinsky KE. Cancer screening in elderly patients: a framework for individualized decision making. Jama. 2001 Jun 6;285 (21): 27 50-6. 11. Kessler TA. Cervical cancer: prevention and early detection. In Seminars in oncology nursing. WB Saunders. 2017 May 1;33(2): 172-183. 12. Parkin DM, Bray F. The burden of HPV-related cancers. Vaccine. 2006 Aug 21;24:S11-25. 13. World Health Organization. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention. World Health Organization; 2021. 14. Cronjé HS. Screening for cervical cancer in the developing world. Best practice & research Clinical obstetrics & gynaecology. 2005 Aug 1;19(4):51 7-29. 15. Arbyn M, Weiderpass E, Bruni L, de Sanjosé S, Saraiya M, Ferlay J, Bray F. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. The Lancet Global Health. 2020 Feb 1;8(2):e191-203. 16. Brabin L, Roberts SA, Farzaneh F, Kitchener HC. Future acceptance of adolescent human papillomavirus vaccination: a survey of parental attitudes. Vaccine. 2006 Apr 12;24 (16):3087-94. 17. Petignat P, Roy M. Diagnosis and management of cervical cancer. Bmj. 2007 Oct 11;335(7623):765-8. 18. Smith RA, Cokkinides V, Brawley OW. Cancer screening in the United States, 2012: a review of current American Cancer Society guidelines and current issues in cancer screening. CA: a cancer journal for clinicians. 2012 Mar;62(2):129-42. 19. Petry KU, Menton S, Menton M, van Loenen-Frosch F, de Carvalho Gomes H, Holz B, Schopp B, GarbrechtBuettner S, Davies P, Boehmer G, van den Akker E. Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: results for 8466 patients. British journal of cancer. 2003 May;88(10):15 70-7. 20. Hussain E, Mahanta LB, Das CR, Talukdar RK. A comprehensive study on the multi-class cervical cancer diagnostic prediction on pap smear images using a fusion-based decision from ensemble deep convolutional neural network. Tissue and Cell. 2020 Aug 1; 65:101347. 21. Mishra GA, Pimple SA, Shastri SS. An overview of prevention and early detection of cervical cancers. Indian Journal of Medical and Paediatric Oncology. 2011 Jul;32(03):125-32. 22. Lechheb Khadija, Berdi Fadoua, Ennafah Wafaa, & Lamsaouru Jamal. Analyse Des Risques a Priori En Unite De Retrocession Au Sein De L'unite De Gestion Des Produits a Statuts Particuliers a L'hmimv De Rabat: Processus De Dispensation. Journal of Medical Research and Health Sciences. 2022; 5(10): 2307–2316.